JPS6045196B2 - Method for producing 1-(2-tetrahydrofuryl)uracils - Google Patents
Method for producing 1-(2-tetrahydrofuryl)uracilsInfo
- Publication number
- JPS6045196B2 JPS6045196B2 JP9396976A JP9396976A JPS6045196B2 JP S6045196 B2 JPS6045196 B2 JP S6045196B2 JP 9396976 A JP9396976 A JP 9396976A JP 9396976 A JP9396976 A JP 9396976A JP S6045196 B2 JPS6045196 B2 JP S6045196B2
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- uracils
- tetrahydrofuryl
- dihydrofuran
- fluorouracil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 239000003054 catalyst Substances 0.000 claims description 6
- 150000004820 halides Chemical class 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 9
- 229960002949 fluorouracil Drugs 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- -1 2-substituted tetrahydrofurans Chemical class 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 4
- 229910001623 magnesium bromide Inorganic materials 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000007259 addition reaction Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CWWIKVUHBBTKHC-UHFFFAOYSA-N 1-(oxolan-2-yl)pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C=CN1C1OCCC1 CWWIKVUHBBTKHC-UHFFFAOYSA-N 0.000 description 1
- YUIHSLYOPKDRCJ-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxy]oxolane Chemical compound CC(C)(C)OC1CCCO1 YUIHSLYOPKDRCJ-UHFFFAOYSA-N 0.000 description 1
- ZVAKZVDJIUFFFP-UHFFFAOYSA-N 2-chlorooxolane Chemical compound ClC1CCCO1 ZVAKZVDJIUFFFP-UHFFFAOYSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
- KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- DCMUJUQQBAFVLJ-UHFFFAOYSA-N oxolan-2-yl acetate Chemical compound CC(=O)OC1CCCO1 DCMUJUQQBAFVLJ-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、1−(2−テトラヒドロフリル)ウラシル類
を工業的に有利に精製造する方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an industrially advantageous method for purifying 1-(2-tetrahydrofuryl)uracils.
本発明によつて得られる化合物の中で、1−(2−テト
ラヒドロフリル)−5−フルオロウラシルは、既に市販
されている優れた制ガン剤である。Among the compounds obtained by the present invention, 1-(2-tetrahydrofuryl)-5-fluorouracil is an excellent anticancer agent that is already commercially available.
これらの化合物の製造法については、従来、数多くの方
法が開発されているが、その反応の形式によつて分類す
ると次の2つの方法が挙げられる。Many methods for producing these compounds have been developed in the past, and the following two methods can be cited depending on the type of reaction.
(1) ウラシル類の水銀またはシリコン誘導体と2−
置換テトラヒドロフラン類を縮合する方法。(1) Mercury or silicon derivatives of uracils and 2-
A method for condensing substituted tetrahydrofurans.
(英国特許第1168391号、ペルキー特許第807
556号、特開昭51−828訝)J(2)ウラシル類
と2−置換テトラヒドロフラン類を縮合する方法。(UK Patent No. 1168391, Pelkey Patent No. 807
No. 556, JP-A-51-828) J(2) Method of condensing uracils and 2-substituted tetrahydrofurans.
(特開昭49−127981号、特開昭51−5218
訝、特開昭51−75097号)上記(1)の方法では
ウラシル類を活性誘導体にする工程を要し、特に水銀を
用いる場合には公害をさけるために多くの後処理工程が
必要不可欠である。またシリコン誘導体を使用する際に
は、シリコン誘導体合成に用いられるヘキサメチルジシ
ラザンやトリメチルシリルクロリドが高価であり、且つ
ウラシル類のシリル誘導体は水に不安定なため、無水条
件を設定する必要があるなど工業的見地から不利な点が
多い。(2)の方法ではウラシル類を活性誘導体にする
必要がないので(1)の方法より優れているが、一方の
反応体である2一置換テトラヒドロフラン類は、2●3
−ジヒドロフランより誘導されるのが一般的である。例
えば、2−クロロテトラヒドロフランは2●5−ジヒド
ロフランと塩化水素の低温付加反応によつて得られ、2
一アセトキシテトラヒドロフランは2●3−ジヒドロフ
ランと酢酸の付加反応によつて得られる。さらに2−t
−ブトキシテトラヒドロフランは、触媒量の塩化水素の
存在下、2・3−ジヒドロフランとt−ブタノールの付
加反応によつて得られる。このように(2)の方法は、
反応体の2一置換テトラヒドロフランを調達するに際し
て2・3−ジヒドロフランより2一置換体に誘導する工
程を要し、また従来繁用されている2−ハロゲノテトラ
ヒドロフラン類は極めて不安定であるため、工業的な利
用には不利な方法である。本発明者らは、このような事
情に鑑みこれらの欠点を有さない有利な工業的製造法を
鋭意研究した結果、2一置換テトラヒドロフランを製造
する工程を必要とせず、2・3−ジヒドロフランを直一
接、反応体として利用できる本発明を完成するに至つた
のである。(JP-A-49-127981, JP-A-51-5218
The above method (1) requires a step to convert uracils into active derivatives, and especially when mercury is used, many post-treatment steps are essential to avoid pollution. be. Furthermore, when using silicon derivatives, it is necessary to set anhydrous conditions because hexamethyldisilazane and trimethylsilyl chloride used in silicon derivative synthesis are expensive, and silyl derivatives of uracils are unstable in water. There are many disadvantages from an industrial standpoint. Method (2) is superior to method (1) because it does not require converting uracils into active derivatives, but one reactant, 2-substituted tetrahydrofuran, is
- It is generally derived from dihydrofuran. For example, 2-chlorotetrahydrofuran is obtained by a low-temperature addition reaction of 2●5-dihydrofuran and hydrogen chloride;
Monoacetoxytetrahydrofuran is obtained by the addition reaction of 2●3-dihydrofuran and acetic acid. Furthermore 2-t
-Butoxytetrahydrofuran is obtained by the addition reaction of 2,3-dihydrofuran and t-butanol in the presence of a catalytic amount of hydrogen chloride. In this way, method (2) is
When procuring 2-monosubstituted tetrahydrofuran as a reactant, a step of deriving 2-substituted tetrahydrofuran from 2,3-dihydrofuran is required, and the 2-halogenotetrahydrofurans that are commonly used in the past are extremely unstable. This method is disadvantageous for industrial use. In view of these circumstances, the present inventors have conducted extensive research into an advantageous industrial production method that does not have these drawbacks, and as a result, the present inventors have found that 2,3-dihydrofuran can be produced without the need for a process for producing 2-substituted tetrahydrofuran. This led to the completion of the present invention, which allows for the direct use of molecule as a reactant.
即ち、本発明は、 一般式(1) (但し、Xは水素またはハロゲン原子をあられす。That is, the present invention General formula (1) (However, X is a hydrogen or halogen atom.
)であられされるウラシル類に2・3−ジヒドロフラン
を反応させ、一般式(■)
(但し、Xは水素またはハロゲン原子をあられ・す。) is reacted with 2,3-dihydrofuran to form a compound of the general formula (■) (where X is hydrogen or a halogen atom).
)であられされる1−(2−テトラヒドロフリル)ウラ
シル類の製造方法である。本発明を反応式で示すと次の
通りである。) is a method for producing 1-(2-tetrahydrofuryl)uracils. The reaction formula of the present invention is as follows.
(但し、Xは水素、またはハロゲン原子をあられす。(However, X is hydrogen or a halogen atom.
)以下本発明を詳細に説明する。本発明の原料である化
合物(1)としては、ウラシル、5−フルオロウラシル
、5−クロロウラシル〔J.Am.Chem.SOc.
、?、3146、(1954)〕、5−ブロモウラシル
〔J.Org.Chem.、幻、11、(1959)〕
、5−ヨードウラシル〔J.BiOl.、Chem.、
旦、30飄(1906)〕等が用いられる。) The present invention will be explained in detail below. Compound (1) which is a raw material of the present invention includes uracil, 5-fluorouracil, and 5-chlorouracil [J. Am. Chem. SOc.
,? , 3146, (1954)], 5-bromouracil [J. Org. Chem. , Illusion, 11, (1959)]
, 5-iodouracil [J. BiOl. , Chem. ,
dan, 30飄 (1906)] etc. are used.
反応体としての2・3−ジヒドロフランは常温、常圧で
安定であり、低温貯蔵すれば長期保存も可能である。ま
た蒸留によつて容易に精製できる。本発明法によつて(
■)以外の副生物は生成しない。この事は、触媒として
、通常のルイス酸、例えば、塩化アルミニウム、塩化錫
、弗化硼素などを用いると、1−(2−テトラヒドロフ
リル)ウラシル類の他、副生物を生するが、これらの代
りに本発明のマグネシウム、リチウム、カリウム等のハ
ロゲン化物またはこれらの混合物を用いることにより、
上述の副生物の生成は認められないからである。本発明
を実施するには化合物(1)と2・3一ジヒドロフラン
を極性溶媒中で加熱すればよいが、工業的には反応速度
を早める目的で触媒の共存下に加熱することが望ましい
。2,3-dihydrofuran as a reactant is stable at normal temperature and pressure, and can be stored for a long period of time if stored at a low temperature. It can also be easily purified by distillation. By the method of the present invention (
■) No by-products other than those produced. This means that when ordinary Lewis acids such as aluminum chloride, tin chloride, and boron fluoride are used as catalysts, by-products are produced in addition to 1-(2-tetrahydrofuryl)uracils. By using the halides of magnesium, lithium, potassium, etc. or mixtures thereof of the present invention instead,
This is because the formation of the above-mentioned by-products is not observed. To carry out the present invention, compound (1) and 2,3-dihydrofuran may be heated in a polar solvent, but from an industrial perspective, it is desirable to heat them in the presence of a catalyst in order to accelerate the reaction rate.
本発明者らは種々検討した結果、反応温度として30〜
200℃、好ましくは60〜150℃の温度が適当であ
ることを見出した。溶媒としてはN−N−ジメチルホル
ムアミド、N−N−ジメチルアセトアミド、ジメチルス
ルホキシド等が優れているが、これらの溶媒とヘキサメ
チルホスホルアミド、またはクラウンエーテル類を適当
な割合で混合したものも好収率を与える。用いられる触
媒はトリエチルアミン、ピリジン、キヌクリジン等の有
機塩基類や、リチウム、ナトリウム、カリウム、マグネ
シウム、カルシウム〜 銅〜アルミ0ウム〜鉄)錫)亜
鉛等のハロゲン化物、酸化物、水酸化物等が触媒作用を
示すが、溶媒に可溶なマグネシウム、リチウム、カリウ
ムのハロゲン化物またはこれらの混合物が特に優れた触
媒作用を示す。例えば、これらのハロゲン化物として、
塩化マグネシウム、塩化リチウム、、ヨウ化カリウム、
臭化マグネシウムが挙げられ、、これらのうち、塩化マ
グネシウムまたは臭化マグネシウムは、本発明において
、優れた触媒作用を示すのみならず、副生物の生成を阻
止し、高収率で1−(2−テトラヒドロフリル)ウラシ
ル類を生成させるので、塩化マグネシウム、または臭化
マグネシウムを触媒として使用するのが特に好ましい。
使用される触媒の量は原料ウラシル類1モルに対して、
0.001モル以上あればよいが、工業的には0.05
〜0.1モルの割合で用いるのが望しい。As a result of various studies, the present inventors found that the reaction temperature was 30~
It has been found that a temperature of 200°C, preferably 60-150°C is suitable. N-N-dimethylformamide, N-N-dimethylacetamide, dimethyl sulfoxide, etc. are excellent as solvents, but mixtures of these solvents with hexamethylphosphoramide or crown ethers in appropriate proportions are also preferred. gives the yield. The catalysts used include organic bases such as triethylamine, pyridine, and quinuclidine, and halides, oxides, and hydroxides such as lithium, sodium, potassium, magnesium, calcium, copper, aluminum, iron, tin, and zinc. The halides of magnesium, lithium, potassium, or mixtures thereof, which are soluble in solvents, exhibit particularly excellent catalytic activity. For example, these halides,
Magnesium chloride, lithium chloride, potassium iodide,
Among these, magnesium chloride or magnesium bromide not only exhibits excellent catalytic activity in the present invention, but also prevents the formation of by-products and converts 1-(2 -tetrahydrofuryl) uracils are formed, it is particularly preferred to use magnesium chloride or magnesium bromide as catalyst.
The amount of catalyst used is based on 1 mole of raw material uracils,
It is sufficient if it is 0.001 mol or more, but industrially it is 0.05 mol or more.
It is desirable to use it in a proportion of ~0.1 mole.
反応終了後、1−(2−テトラヒドロフリル)ウラシル
類を単離精製するには、反応液を減圧下て濃縮乾固し、
残渣を水に不溶の有機溶媒、好ましくはクロロホルムに
溶解させ、有機溶媒に不溶の原料を濾去後、濾液を水洗
し、芒硝にて乾燥すれば、容易に粗結晶が得られる。ま
た必要に応じ、残渣を酢酸エチルから再結晶すれば白色
の結晶が収率よく容易に得られる。上述のように本反応
の実施は極めて簡単で、未反応ウラシル類の回収も容易
である。After completion of the reaction, in order to isolate and purify 1-(2-tetrahydrofuryl)uracils, the reaction solution is concentrated to dryness under reduced pressure.
Crude crystals can be easily obtained by dissolving the residue in a water-insoluble organic solvent, preferably chloroform, filtering off raw materials insoluble in the organic solvent, washing the filtrate with water, and drying with sodium sulfate. Furthermore, if necessary, white crystals can be easily obtained in good yield by recrystallizing the residue from ethyl acetate. As mentioned above, this reaction is extremely simple to carry out, and unreacted uracils can be easily recovered.
次に本発明の方法を実施例を挙げて説明する。Next, the method of the present invention will be explained by giving examples.
実施例1還流冷却器と攪拌機を付したフラスコ中、5−
フルオロウラシル1.0y(7.7ミリモル)と塩化マ
グネシウム73.3m9(0.77ミリモル)をN−N
−ジメチルホルムアミド10m1に溶解し、2・3−ジ
ヒドロフラン0.8f(11.4ミリモル)を加え12
0℃にて3時間攪拌する。反応液を減圧下で濃縮乾固し
、残渣にクロロホルム25mtを加えて溶解しクロロホ
ルムに不溶の原料5−フルオロウラシルを濾去後、濾液
を水洗し芒硝にて乾燥する。クロロホルムを減圧留去し
、残渣を酢酸エチルから再結晶するとMpl66〜16
8酢の白色結晶1.1y(71%)を得る。本化合物は
公知化合物との混融試験および赤外線吸収スペクトルの
比較によつて1−(2ーテトラヒドロフリル)−5−フ
ルオロウラシルであることを確認した。クロロホルムの
洗滌水を減圧下乾固し、前記クロロホルム不溶分と合つ
して水より再結晶し、0.2ダ(20%)の5−フルオ
ロウラシルを回収した。実施例2
5−フルオロウラシル1.0g(7.7ミリモル)と塩
化マグネシウム73.3m9(0.77ミリモル)をN
・N−ジメチルホルムアミド10m1に溶解し、2・3
ージヒドロフラン540mg(7.7ミリモル)を加え
120℃で1時間攪拌後、2・3−ジヒドロフラン54
0m9を追加して120℃でさらに3時間反応させる。Example 1 In a flask equipped with a reflux condenser and a stirrer, 5-
Fluorouracil 1.0y (7.7 mmol) and magnesium chloride 73.3m9 (0.77 mmol) were mixed in N-N
-Dissolved in 10 ml of dimethylformamide, added 0.8 f (11.4 mmol) of 2,3-dihydrofuran and 12
Stir at 0°C for 3 hours. The reaction solution was concentrated to dryness under reduced pressure, 25 mt of chloroform was added to the residue to dissolve it, and the raw material 5-fluorouracil insoluble in chloroform was filtered off. The filtrate was washed with water and dried over sodium sulfate. When chloroform was distilled off under reduced pressure and the residue was recrystallized from ethyl acetate, Mpl66-16
1.1y (71%) of white crystals of 8 vinegar are obtained. This compound was confirmed to be 1-(2-tetrahydrofuryl)-5-fluorouracil by a blending test with known compounds and a comparison of infrared absorption spectra. The chloroform washing water was dried under reduced pressure, combined with the chloroform-insoluble matter, and recrystallized from water to recover 0.2 Da (20%) of 5-fluorouracil. Example 2 1.0 g (7.7 mmol) of 5-fluorouracil and 73.3 m9 (0.77 mmol) of magnesium chloride were mixed with N
・Dissolved in 10ml of N-dimethylformamide, 2.3
After adding 540 mg (7.7 mmol) of 2,3-dihydrofuran and stirring at 120°C for 1 hour, 540 mg (7.7 mmol) of 2,3-dihydrofuran was added.
0 m9 was added and the reaction was further carried out at 120°C for 3 hours.
後処理は実施例1と同様に行い1−(2−テトラヒドロ
フリル)−5−フルオロウラシル1.2−f(79.1
%)を得た。実施例3
5−フルオロウラシル1.0y(7.7ミリモル)、塩
化リチウム32.6m9(0.77ミリモル)およびヨ
ウ化カリウム1.28g(7.7ミリモル)をN−N−
ジノメチルホルムアミド10mtに溶解し、2・3−ジ
ヒドロフラン0.8y(11.6ミリモル)を加え、1
200Cで5時間反応後.実施例1と同様に処理して、
1−(2−テトラヒドロフリル)−5−フルオロウラシ
ル1.3y(83%)を得た。The post-treatment was carried out in the same manner as in Example 1, and 1-(2-tetrahydrofuryl)-5-fluorouracil 1.2-f (79.1
%) was obtained. Example 3 1.0 y (7.7 mmol) of 5-fluorouracil, 32.6 m9 (0.77 mmol) of lithium chloride and 1.28 g (7.7 mmol) of potassium iodide were dissolved in N-N-
Dissolved in 10mt of dinomethylformamide, added 0.8y (11.6 mmol) of 2,3-dihydrofuran, and
After reaction at 200C for 5 hours. Treated in the same manner as in Example 1,
1.3y (83%) of 1-(2-tetrahydrofuryl)-5-fluorouracil was obtained.
5参考例1
5−フルオロウラシル1.0y(7.7ミリモル)、2
・3−ジヒドロフラン0.8g(11.6ミリモル)お
よびトリエチルアミン78.5m9(0.77ミリモル
)をN●N−ジメチルホルムアミド10m1に溶解し9
130℃で5時間反応させ実施例1と同様に後処理して
、1−(2−テトラヒドロフリル)−5−フルオロウラ
シル0.96V(62%)を得た。5 Reference Example 1 5-fluorouracil 1.0y (7.7 mmol), 2
・Dissolve 0.8 g (11.6 mmol) of 3-dihydrofuran and 78.5 m9 (0.77 mmol) of triethylamine in 10 m1 of N●N-dimethylformamide.9
The reaction was carried out at 130° C. for 5 hours and post-treated in the same manner as in Example 1 to obtain 1-(2-tetrahydrofuryl)-5-fluorouracil 0.96V (62%).
実施例45−フルオロウラシル1.0y(7.7ミリモ
ル)、塩化マグネシウム85.7wL9(0.89ミリ
モル)をN・N−ジメチルアセトアミド10m1に溶解
し2・3−ジヒドロフラン0.8f(11.6ミリモル
)を加え120℃で3時間反応させ、実施例1と同様に
処理して1−(2−テトラヒドロフリル)−5−フルオ
ロウラシル855m9(55%)を得た。Example 4 1.0 y (7.7 mmol) of 5-fluorouracil and 85.7 wL9 (0.89 mmol) of magnesium chloride were dissolved in 10 ml of N.N-dimethylacetamide, and 0.8 f (11.6 mmol) of 2,3-dihydrofuran was dissolved. The mixture was reacted at 120° C. for 3 hours, and treated in the same manner as in Example 1 to obtain 855 m9 (55%) of 1-(2-tetrahydrofuryl)-5-fluorouracil.
実施例5
ウラシル1.12y(10ミリモル)、塩化マグネシウ
ム85.8m9(0.89ミリモル)をN−N−ジメチ
ルホルムアミド10mLに溶解し、2・3−ジヒドロフ
ラン0.9y(12ミリモル)を加え120℃にて3時
間反応させ、実施例1と同様に後処理してMplOO℃
の1−(2−テトラヒドロフリル)ウラシル1.3y(
72%)を得た。Example 5 1.12y (10 mmol) of uracil and 85.8m9 (0.89 mmol) of magnesium chloride were dissolved in 10 mL of N-N-dimethylformamide, and 0.9y (12 mmol) of 2,3-dihydrofuran was added. The reaction was carried out at 120°C for 3 hours, and post-treated in the same manner as in Example 1 to obtain MplOO°C.
1-(2-tetrahydrofuryl)uracil 1.3y(
72%).
実施例6
5−フルオロウラシル1.0g(7.7ミリモル)およ
び無水臭化マグネシウム142mg(イ).77ミリモ
ル)をジオキサン20m1に懸濁し、さらに2●3−ジ
ヒドロフラン1.08y(15.4ミリモル)を加え封
管中120℃で1時間攪拌する。Example 6 1.0 g (7.7 mmol) of 5-fluorouracil and 142 mg (a) of anhydrous magnesium bromide. 77 mmol) was suspended in 20 ml of dioxane, 1.08 y (15.4 mmol) of 2●3-dihydrofuran was added, and the mixture was stirred at 120° C. for 1 hour in a sealed tube.
反応後不溶の臭化マグネシウムを濾去し、濾液を減圧下
に濃縮乾固する。After the reaction, insoluble magnesium bromide is removed by filtration, and the filtrate is concentrated to dryness under reduced pressure.
Claims (1)
は水素、またはハロゲン原子をあらわす。 )であらわされるウラシル類にマグネシウム、リチウム
、カリウムのハロゲン化物から選ばれる触媒の存在下2
・3−ジヒドロフランを反応させる一般式(II)▲数式
、化学式、表等があります▼(II)(但し、Xは水素、
またはハロゲン原子をあらわす。 )であらわされる1−(2−テトラヒドロフリル)ウラ
シル類の製造方法。[Claims] 1. General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (However, X
represents a hydrogen or halogen atom. ) in the presence of a catalyst selected from halides of magnesium, lithium, and potassium 2
・General formula (II) for reacting 3-dihydrofuran ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ (II) (However, X is hydrogen,
Or represents a halogen atom. ) A method for producing 1-(2-tetrahydrofuryl)uracils.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9396976A JPS6045196B2 (en) | 1976-08-09 | 1976-08-09 | Method for producing 1-(2-tetrahydrofuryl)uracils |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9396976A JPS6045196B2 (en) | 1976-08-09 | 1976-08-09 | Method for producing 1-(2-tetrahydrofuryl)uracils |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5321178A JPS5321178A (en) | 1978-02-27 |
| JPS6045196B2 true JPS6045196B2 (en) | 1985-10-08 |
Family
ID=14097219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9396976A Expired JPS6045196B2 (en) | 1976-08-09 | 1976-08-09 | Method for producing 1-(2-tetrahydrofuryl)uracils |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6045196B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5331673A (en) * | 1976-08-28 | 1978-03-25 | Nikken Kagaku Kk | Synthesis of n-substituted-uracils |
| JPH0348885Y2 (en) * | 1984-10-04 | 1991-10-18 | ||
| JPS61138767U (en) * | 1985-02-20 | 1986-08-28 | ||
| JPH0534300Y2 (en) * | 1986-08-25 | 1993-08-31 | ||
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US7119202B1 (en) | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
-
1976
- 1976-08-09 JP JP9396976A patent/JPS6045196B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5321178A (en) | 1978-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA007953B1 (en) | Processes for the preparation of 4-[[4-[[-4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
| EP1176150B1 (en) | Process for the preparation of trifluorothymidine derivatives | |
| JPH072798A (en) | Production of 5-halogenopyrimidine derivative | |
| JP2001114767A (en) | Production of pyrimidine compound and production of its intermediate | |
| US4121037A (en) | Process for producing 5-fluorouracil derivative with a calcium chloride catalyst | |
| CN117658936B (en) | Synthesis method of 3,5, 6-trichloro- [1,2,4] -triazine | |
| KR820000785B1 (en) | Process for preparing 1-(tetrahydro-2-furanyl)-5-fluorouracil | |
| JP3001626B2 (en) | 2-Chloropropionaldehyde trimer and method for producing the same | |
| JP2564141B2 (en) | Method for producing alkylbenzothiazoles | |
| US4703121A (en) | Process for the preparation of 5-fluorocytosine | |
| JPS637554B2 (en) | ||
| JPH05213903A (en) | Production of acyclonucleoside derivative | |
| JPH075554B2 (en) | Process for producing 5-bromopyridone-3-carboxamide compound | |
| JPH03157362A (en) | Benzyl halides | |
| JPH10287657A (en) | Production of radiosensitizer | |
| JPS609036B2 (en) | Production method of uracil derivatives | |
| JP2809972B2 (en) | Method for producing 5-trifluoromethyluracil | |
| JPS6029397B2 (en) | Method for producing 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil | |
| JPS6044311B2 (en) | Production method of uracil derivatives | |
| JPS59504B2 (en) | Imidocarboxylic ester Allyl ester | |
| JPS5993060A (en) | Preparation of cytosines | |
| JPH0378865B2 (en) | ||
| JPS6031832B2 (en) | Method for producing 1-(2'-tetrahydrofuryl)-5-fluorouracil | |
| JPH01272559A (en) | 2,6-diethylaniline derivative and production thereof | |
| JPH07107028B2 (en) | 2,6-Diethyl-4-phenoxyalinine derivative and method for producing the same |